Skandinaviska Enskilda Banken Ab (Publ) Adverum Biotechnologies, Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 12, 2020	SELL	$10.3 - $21.64 $81,370 - $170,956	-7,900 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$8.53 - $25.64 $67,387 - $202,556	7,900 New	7,900 $165,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $612M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.